Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-29T11:54:58.674Z Has data issue: false hasContentIssue false

Expression and Co-Localization of C-Type Natriuretic Peptide and Endothelin in Human Kidney

Published online by Cambridge University Press:  02 July 2020

C. Wei
Affiliation:
, Cardiorenal Molecular Research, Departments of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21201
J. C. Burnett Jr.
Affiliation:
Department of Medicine, Mayo Clinic, Rochester, MN, 55905
Get access

Extract

C-type natriuretic peptide (CNP) is an endothelium-drived vasorelaxing factor which is present in human plasma, urine and renal epithelial cells. Endothelin (ET) is a potent renal and systemic vasoconstrictor and sodium regulating peptide. To date, the localization of C-type natriuretic peptide and endothelin gene expression in human kidney remains poorly defined.

We determined the co-localization of C-type natriuretic peptide and endothelin mRNA in normal human kidney using in situ hybridization (ISH) with synthesized human C-type natriuretic peptide or human endothelin oligonucleotide probes together with immunohistochemical staining (IHCS) with human CNP-22 and ET-1 antibodies with no crossreactivity. The sections treated with nonimmune rabbit serum (NRS) demonstrated no immunoperoxidase activity. Human renal tissue (n=7) was obtained from biopsy of normal cadaveric donor kidneys and normal autopsy specimens.

In situ hybridization (Figure 1) demonstrated that C-type natriuretic peptide and endothelin mRNA presence in human kidney which was localized to proximal and distal tubes with similar intensities.

Type
Pathology
Copyright
Copyright © Microscopy Society of America

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References:

1.Borgeson, D. D., et al. Clin Sci (1998) 95, 195202.CrossRefGoogle Scholar
2.Brenner, D., Gerstberger, R.. Endocrinology (1999) 140, 16221629.CrossRefGoogle Scholar
3.Lai, K. N., et al. J Hypertens (1999) 17, 575583.CrossRefGoogle Scholar
4.Wihelm, S. M., et al. Kidney Int (1999) 55, 10111018CrossRefGoogle Scholar
5.Ruschitzka, R., et al. J Am Soc Nephrol (1999) 10, 953962Google Scholar
6.Choukroun, G., et al. J Clin Invest (1998) 102, 13111320.CrossRefGoogle Scholar
5. This research was supported in part by grants from the NIH (HL03174 & HL61299, C. Wei), AHA-MD, NKF and University of Maryland School of Medicine.Google Scholar